Skip to main content
SNDX logo

SNDX · Syndax Pharmaceuticals Inc

Track SNDX — free
$19.84 +0.76 (+3.98%) At close · Aug 14
Market Cap
$1.77B
Shares
89.30M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-07-08 MICHAEL METZGER 32,375
2026-06-12 Botwood Nicholas A.J. 31,235
2026-06-11 Botwood Nicholas A.J. 34,280
2026-06-01 Goldan Keith A. 1,177
2026-06-01 Metzger Michael A 6,847
2026-02-09 Metzger Michael A 17,159
2026-02-09 Goldan Keith A. 3,410
2026-02-06 Metzger Michael A 7,412
2026-02-06 Goldan Keith A. 2,082
2025-09-08 MICHAEL METZGER 157,307
2025-08-18 DENNIS G PODLESAK 14,400
2025-08-14 DENNIS G PODLESAK 43,200
2025-07-16 Metzger Michael A 7,534
2025-07-16 Goldan Keith A. 1,296
2025-07-10 Gallagher Neil 9,679
2025-03-04 MICHAEL METZGER 13,888
2025-02-10 Metzger Michael A 13,288
2025-02-10 Goldan Keith A. 3,777
2025-02-10 Gallagher Neil 4,618
2023-08-09 BRIGGS MORRISON 52,855
2023-08-02 Meury William 83,000
2023-07-10 BRIGGS MORRISON 52,855
2023-06-09 BRIGGS W MORRISON 52,855
2023-05-09 BRIGGS W MORRISON &ANGELA HOOVER MORRISON JT TEN 52,855
Showing 1–24 of 24 filings
Key facts CIK 1395937 CUSIP 87164F105 13F (30d) 233 filings 227 filers Visit website Investor relations